Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies

Trial Identifier: D5660C00017
Sponsor: AstraZeneca
NCTID:: NCT03394144
Start Date: January 2018
Primary Completion Date: April 2019
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Japanese translation

Trial Locations

Country Location
Japan Kashiwa, Japan, 277-8577
Japan Matsuyama-shi, Japan, 791-0280